Wisconsin's SHINE Medical, NorthStar Medical in line for $15M apiece from U.S. DOE

Wisconsin's SHINE Medical Technologies and Northstar Medical Radioisotopes are in negotiations with the Department of Energy’s National Nuclear Security Administration to receive up to $15 million in funding each for their production of Molybdenum-99 (Mo-99).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.